DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Pilot Study With a Diffractive Trifocal IOL (POD AY 26P FineVision)

Information source: Physiol
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Bilateral Cataract

Intervention: trifocal intraocular lens (Device)

Phase: N/A

Status: Not yet recruiting

Sponsored by: Physiol

Official(s) and/or principal investigator(s):
Irit Bahar, MD, Principal Investigator, Affiliation: Rabin Medical Center

Summary

The principal objective of the study is to determine the visual acuity at far, intermediate and near distances tested with optotypes at different distances from the eyes and tested with defocus addition lenses of patients implanted bilaterally with the POD 26P AY FineVision. Secondary objective will be to test the glare and contrast sensitivity.

Clinical Details

Official title: Pilot Study With a Diffractive Trifocal IOL (POD AY 26P FineVision)

Study design: Observational Model: Case-Only, Time Perspective: Prospective

Primary outcome: Visual acuity

Secondary outcome: Contrast sensitivity

Detailed description: This study is a pilot study. As such it will recruit a limited number of patients : 20. Patients recruited will suffer from cataract, have no comorbidity, expressed the desire for spectacle independence and have realistic expectations. Descriptive statistics will be used to determine the visual acuities at any distance. The occurence of glare and the determination of the contrast sensitivity will also be determined.

Eligibility

Minimum age: 21 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- - Age-related cataract

- Preoperative Corneal astigmatism < 0. 75 D

- Age 21 and older

- Visual Acuity > 0. 05

- Normal findings in the medical history and physical examination unless the

investigator considers an abnormality to be clinically irrelevant.

- Patient willing multifocal implantation and with realistic expectations.

Exclusion Criteria:

- Relevant other ophthalmic diseases such as pseudoexfoliation syndrome, floppy iris

syndrome, corneal pathologies, retinal pathology (diabetic maculopathy, myopic maculopathy, age related macular degeneration...)

- Previous ocular surgery or trauma.

Locations and Contacts

Rabin Medical Center 49Th Jabotinsky Street, Petach Tikva, Israel; Not yet recruiting
Vivi Dagan, Phone: 972-3-9377199, Email: EYECLINIC@CLALIT.ORG.IL
Irit Bahar, MD, Principal Investigator
Additional Information

Starting date: February 2014
Last updated: January 20, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017